Senior insider sale
Chief Executive Officer at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$736.0K
200K shares
What this filing means
GIBSON CHRISTOPHER plans to sell 200K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $736.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/7/2026ACC: 0001959173-26-002807
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
200K
Shares to sell
$736.0K
Approx. market value
40K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Founders Shares
Compensation
9/1/2016
40KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2016 | Founders Shares Compensation | 40K | — |
| Total | 40K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
40K
Market value
$130.0K
3/23/2026
—Completed
Units to sell
40K
Market value
$138.4K
2/19/2026
—Completed
Units to sell
40K
Market value
$164.8K
2/4/2026
—Completed
Units to sell
40K
Market value
$178.8K
1/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
40K
Market value
$124.0K
4/7/2026
Total
Units
200K
Value
$736.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/23/2026 | 40K | $130.0K | — | Completed |
2/19/2026 | 40K | $138.4K | — | Completed |
2/4/2026 | 40K | $164.8K | — | Completed |
1/20/2026 | 40K | $178.8K | — | Completed |
| Planned — Approximate Date | ||||
4/7/2026 | 40K | $124.0K | NASDAQ | Planned |
| Total | 200K | $736.0K | ||